PL2839836T3 - Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego - Google Patents

Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego

Info

Publication number
PL2839836T3
PL2839836T3 PL14186663T PL14186663T PL2839836T3 PL 2839836 T3 PL2839836 T3 PL 2839836T3 PL 14186663 T PL14186663 T PL 14186663T PL 14186663 T PL14186663 T PL 14186663T PL 2839836 T3 PL2839836 T3 PL 2839836T3
Authority
PL
Poland
Prior art keywords
probiotics
respiratory disease
reducing symptoms
symptoms
reducing
Prior art date
Application number
PL14186663T
Other languages
English (en)
Inventor
Gregory Leyer
Arthur Ouwehand
Original Assignee
Dupont Nutrition Biosciences Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39268947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2839836(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dupont Nutrition Biosciences Aps filed Critical Dupont Nutrition Biosciences Aps
Publication of PL2839836T3 publication Critical patent/PL2839836T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
PL14186663T 2006-10-02 2007-09-14 Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego PL2839836T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84866206P 2006-10-02 2006-10-02
EP14186663.2A EP2839836B1 (en) 2006-10-02 2007-09-14 Probiotics for use in reducing symptoms of respiratory disease
EP07838266.0A EP2068899B1 (en) 2006-10-02 2007-09-14 Lactobacillus acidophilus for use in reducing the incidence and duration of respiratory infections

Publications (1)

Publication Number Publication Date
PL2839836T3 true PL2839836T3 (pl) 2018-02-28

Family

ID=39268947

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14186663T PL2839836T3 (pl) 2006-10-02 2007-09-14 Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego
PL07838266T PL2068899T3 (pl) 2006-10-02 2007-09-14 Lactobacillus acidophilus do zastosowania w zmniejszaniu częstości występowania i czasu trwania zakażeń dróg oddechowych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07838266T PL2068899T3 (pl) 2006-10-02 2007-09-14 Lactobacillus acidophilus do zastosowania w zmniejszaniu częstości występowania i czasu trwania zakażeń dróg oddechowych

Country Status (12)

Country Link
US (5) US20100040579A1 (pl)
EP (2) EP2068899B1 (pl)
JP (3) JP5896589B2 (pl)
KR (2) KR101485200B1 (pl)
CN (1) CN101528244B (pl)
AU (1) AU2007302715B2 (pl)
BR (1) BRPI0719787A2 (pl)
DK (2) DK2839836T3 (pl)
ES (2) ES2547480T3 (pl)
MX (1) MX2009003260A (pl)
PL (2) PL2839836T3 (pl)
WO (1) WO2008042101A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2835860B1 (en) 2009-12-02 2018-03-07 KMW Inc. Device selection structure
JP5885287B2 (ja) * 2010-09-02 2016-03-15 アサヒカルピスウェルネス株式会社 インフルエンザの予防および／または治療剤
EP2627198B1 (en) * 2010-10-15 2015-09-02 Chr. Hansen A/S Immunoadjuvant
EP2455093A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
US10357506B2 (en) 2013-11-15 2019-07-23 Nestec S.A. Compositions for use in the prevention or treatment of URT infections in infants or young children at risk
CN103798392B (zh) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
AU2016227595B2 (en) 2015-03-05 2020-08-27 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
EP4040984A4 (en) 2019-09-25 2024-01-17 Tall Goods Llc METHOD FOR PRODUCING PROBIOTICALLY ENHANCED BIRD EGGS AND EGG PRODUCTS AND FORMULATIONS THEREOF

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007A (en) * 1845-04-22 Improvement in separating tannin and coloring-matter in quercitron-bark
ES2283027T3 (es) * 1996-11-29 2007-10-16 Bio K + International Inc. Fermento lactico que comprende una cepa particular de lactobacilus acidofilus y utilizacion del mismo.
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
BR0315209A (pt) 2002-10-11 2005-08-16 Wyeth Corp Formulações nutritivas que contêm substâncias simbióticas
EP1696941A1 (en) * 2003-12-17 2006-09-06 N.V. Nutricia Lactic acid producing bacteria and lung function
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
CA2470090A1 (fr) * 2004-06-18 2005-12-18 Bio-K Plus International Inc. Bacteries lactiques et leurs usages dans la prevention de diarrhee associee aux antibiotiques
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
KR101355266B1 (ko) * 2005-02-15 2014-02-06 배리 알 골딘 생균 및 분리된 β­글루칸을 포함하는 식품 및 이들의 사용방법
US20070020249A1 (en) * 2005-04-29 2007-01-25 Downs Bernard W Compositions for prevention and treatement of symptoms of gastrointestinal distress
WO2007040445A1 (en) 2005-10-06 2007-04-12 Probi Ab Use of lactobacillus for treatment of virus infections

Also Published As

Publication number Publication date
AU2007302715A1 (en) 2008-04-10
ES2650375T3 (es) 2018-01-18
DK2068899T3 (da) 2015-09-28
US20230256037A1 (en) 2023-08-17
MX2009003260A (es) 2009-05-11
EP2068899A2 (en) 2009-06-17
WO2008042101A3 (en) 2009-04-09
BRPI0719787A2 (pt) 2014-11-25
JP2016128478A (ja) 2016-07-14
DK2839836T3 (en) 2017-12-04
PL2068899T3 (pl) 2015-12-31
KR20090063222A (ko) 2009-06-17
KR20140002069A (ko) 2014-01-07
US20100040579A1 (en) 2010-02-18
CN101528244A (zh) 2009-09-09
KR101474188B1 (ko) 2014-12-17
EP2839836B1 (en) 2017-08-30
ES2547480T3 (es) 2015-10-06
JP2014058558A (ja) 2014-04-03
AU2007302715B2 (en) 2013-01-31
JP2010505824A (ja) 2010-02-25
KR101485200B1 (ko) 2015-01-26
WO2008042101A2 (en) 2008-04-10
US20180000875A1 (en) 2018-01-04
US20200316145A1 (en) 2020-10-08
EP2068899B1 (en) 2015-07-01
JP5896589B2 (ja) 2016-03-30
CN101528244B (zh) 2012-01-11
EP2839836A1 (en) 2015-02-25
US20140356329A1 (en) 2014-12-04

Similar Documents

Publication Publication Date Title
PL2839836T3 (pl) Probiotyki do zastosowania przy redukowaniu objawów choroby układu oddechowego
PL2077729T3 (pl) Doustne postacie dawkowania probiotyku
GB2453188B (en) Use of compounds in the manufacture of medicaments for treatment of regional fat deposits
GB0625659D0 (en) Therapeutic compounds and their use
EP2094154A4 (en) BREATHING THE FLIGHT OF HORSES
IL198090A0 (en) Ventilator for rapid response to respiratory disease conditions
EP2010187A4 (en) CONNECTIONS FOR DISEASES AND FUNCTIONAL DISORDERS
PL2007457T3 (pl) Inhalator
IL193693A0 (en) Purine compounds and methods of use thereof
IL195247A0 (en) Inhaler
IL236360A0 (en) Inhalable medicine
EP2164505A4 (en) TREATMENT OF CHRONIC LUNG DISEASE
EP2036566A4 (en) USE OF 20 (S) -PROTOPANOXADIOL IN THE PREPARATION OF ANTIDEPRESSIVA
IL182407A0 (en) Use of agomelating in obtaining medicaments intended for the treatment of generalized anxiety disorder
GB2436290B (en) Patient calming arrangements
HK1141708A1 (en) Agent for treatment of pulmonary disease
EP2056858A4 (en) TREATMENT OF PULMONARY DISEASE CONDITIONS
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
ZA201001207B (en) Therapeutic formulations for the treatment of cold and flu-like symptoms
GB2434754B (en) Inhaler
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP2043484A4 (en) AIR MATTRESS FOR ONE-TIME USE
EP2123299A4 (en) THERAPEUTIC AGENT FOR INTERSTITIAL PULMONARY DISEASE COMPRISING ANTI-HMGB-1 ANTIBODY
GB0701456D0 (en) Treatment for respiratory disease
EP1963768A4 (en) EVAPORATOR AND THE SAME METHOD